Preben von Magnus

Preben Christian Alexander von Magnus (25 February 1912 – 9 August 1973) was a Danish virologist who is known for his research on influenza, polio vaccination and monkeypox.

He gave his name to the Von Magnus phenomenon.

Preben von Magnus was born in Copenhagen on 25 February 1912 to the Livonian landowner Constantin Woldemar von Magnus and physician Rigmor von Magnus (née Herbst).

He graduated from the Gammel Hellerup Gymnasium in 1931 and became a graduate of law and a Candidate of Medicine from the University of Copenhagen in 1939.

Following his junior hospital posts in 1943, he worked at the Statens Serum Institut, and in 1944 published, with his wife Herdis von Magnus, the initial study that led to the discovery of what today is known as the Von Magnus phenomenon.

Naturally occurring pox infections in non-human primates were first reported by Rijk Gispen in 1949.

Due to the similar clinical appearances, some of these cases may have been due to monkeypox rather than smallpox.

In the 1950s, together with his wife the virologist Herdis von Magnus, he directed the first Danish vaccination programme against polio.

Following Jonas Salk's discovery of a polio vaccine in the early 1950s, the United States State Department sent details of polio vaccine manufacturing to those that requested it, with the permission of President Eisenhower.

Von Magnus and his wife Herdis were not only Salk's lifelong friends, but were also appointed by the Danish government to direct the vaccination of all 7 to 12 year olds.

In 1951, he was a member of the UNRRA aid to South Korean civilians.

He served on the Danish hospital ship MS Jutlandia and he became a member of the Advisory Panel on Virus Disease of the World Health Organization.

Von Magnus became Doctor of Medical Science in 1952, after defending his doctoral dissertation Propagation of the PR8 strain of influenza A virus in chick embryos.

The Statens Serum Institut produced its own modified polio vaccine using techniques based on what the von Magnus's had learnt in the spring of 1953, when they accepted an invitation to visit Salk's laboratory.

Due to the limited supply of inactivated virus, the Danish institute administered the vaccine subcutaneously, requiring smaller doses.

In 1958, he was the first to confirm the identity of the monkeypox virus and to describe monkeypox in laboratory crab-eating Macaques during two outbreaks of the disease in the summer and autumn of that year.

In 1958, von Magnus was the first to confirm the identity of the monkeypox virus and to describe monkeypox in laboratory crab-eating Macaques during two outbreaks of the disease in the summer and autumn of that year.

A little more than thirty cases of monkeys with monkeypox were reported, more than fifty days after their arrival by ship from Singapore.

There were no deaths and no monkey-to-human transmission.

Not all the exposed monkeys exhibited the illness.

He isolated the virus from monkey kidney tissue cell culture and from the chorioallantoic membrane of chick embryos.

The characteristic appearance of the virus led von Magnus to elucidate that it belonged to the smallpox-vaccinia group of Poxviridae.

In 1959 he was appointed director of the Statens Serum Institut.

He represented Denmark at the 1959 Pugwash Conferences on Science and World Affairs where he explained that respiratory viruses such as influenza and the common cold were unsuitable as biological weapons.

He was director of the Danish Influenza Centre and in 1959 was appointed director of the Statens Serum Institut.

In 1959, von Magnus represented Denmark at the 1959 Pugwash Conferences on Science and World Affairs, where he explained that respiratory viruses such as influenza and the common cold were unsuitable as biological weapons as they rarely produced severe effects and were already common among human populations, resulting in some level of immunity.

He warned however, that such viruses were stable and easily cultured and therefore the emergence of a new virus with a more serious impact, through mutation or deliberate cultivation, could not be ruled out.

In addition, in 1960, he became an advisor to the Danish National Health Service on bacteriology and serology.

He was a member of the Akademiet for de Tekniske Videnskaber from 1960, of the Royal Danish Academy of Sciences and Letters from 1968, and became Knight of the Order of the Dannebrog in 1965.

He became a Knight of the Order of the Dannebrog in 1965.

In 1965, he was appointed to the Danish Science Advisory Council, where he served as its vice-chairman and chairman.

Three years later he became a member and co-founder of the Danish Royal Scientific Society.

Despite the inability to isolate them, von Magnus discovered defective interfering particles (DIPs) using the "influenza virus system".

He called them "incomplete" or "immature".

He found that when viruses were expanded at high doses, "incomplete viruses" or "particles" were produced and that these interfered with viral replication.

This resulted in a reduction in the infectivity of influenza.

The physiological interaction between DIPs and the host, and the effect of DIPs on the replication of infectious standard virus, have since been studied.

In 1968, the WHO reported that it was not infrequent to observe outbreaks of suspected smallpox and monkeypox in laboratory monkeys at more than twenty-five biological institutions around the world and that further research was warranted to assess susceptibity in humans.

It was not until 1970, more than ten years after von Magnus identified the virus, that monkeypox was first identified in humans.

He received a Doctor honoris causa from Glasgow University in 1971.